PMA device
En Vista One Piece Hydrophobic Acrylic Lens
Bausch & Lomb, Inc. · Intraocular Lens (HQL, Class III) · First FDA decision May 30, 2012, newest Aug 1, 2014Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
0
Naming "En Vista One"
MAUDE reports
0
Brand "En Vista One", since 2015
PubMed studies
0
Mentioning "En Vista One"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing En Vista One Piece Hydrophobic Acrylic Lens
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- EN VISTA ONE PIECE HYDROPHOBIC ACRYLIC LENSPMA supplement
P910056-S017 · Decided Aug 1, 2014 · 88 days after receipt · Normal 180 Day Track
Device type: intraocular lens (HQL) · Ophthalmology
- EN VISTA ONE PEICE HYDROPHOBIC ACRYLIC LENS, MODEL MX60PMA supplement
P910056-S010 · Decided May 30, 2012 · 261 days after receipt · Normal 180 Day Track
Device type: intraocular lens (HQL) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Intraocular Lenses (IOLs)National determinationOn the books80.12Updated Aug 17, 2023
- Intraocular PhotographyNational determinationOn the books80.6Updated Apr 17, 2020
- Ophthalmic Biometry for Intraocular Lens Power CalculationLocal determinationIn effectL33621Wellpoint FederalUpdated Jul 14, 2026
- Ophthalmic Biometry for Intraocular Lens Power CalculationLocal determinationIn effectL34181CGS Administrators, LLCUpdated May 29, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40385WPS Insurance CorporationUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40356CGS Administrators, LLCUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40367Palmetto GBAUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40363National Government Services, Inc.Updated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "En Vista One", any status and sponsor, newest update first.
No registered device study names "En Vista One".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "En Vista One", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HQL
40,785 reports: 26,247 malfunction, 14,467 injury, 2 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2552-2020 · Started Jun 9, 2020
Reason given: The toric axis marks were misaligned (from the expected position in relation to the haptics) on an implanted lens.
Cause as FDA categorized it: Unknown/Undetermined by firm · Device type: Intraocular Lens (HQL)
Z-0628-2019 · Started Nov 5, 2018
Reason given: Cosmetic imperfections on the surface of some lenses.
Cause as FDA categorized it: Process control · Device type: Intraocular Lens (HQL)
Published research
The most relevant PubMed records for "En Vista One"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HQL.
- SENSAR Soft Acrylic Posterior Chamber IOLJohnson & Johnson Surgical Vision, Inc. · PMA 2025
- Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery SystemAlcon Laboratories, LLC · PMA 2026
- TECNIS Toric 1-Piece Intraocular Lense (IOLs)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- TECNIS Symfony Toric Extended Range of Vision IOLsJohnson & Johnson Surgical Vision, Inc. · PMA 2021
- Akreos Posterior Chamber Intraocular LensBausch & Lomb, Inc. · PMA 2021
- Acrysof Iq Toric IOL with the Ultrasert Pre Loaded Delivery System ModelsAlcon Laboratories, Inc. · PMA 2017
- Softec Hd Posterior Chamber Intraocular Lens (Pciol)Lenstec, Inc. · PMA 2014
- Posterior Chamber Intraocular LensesAaren Scientific · PMA 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.